Tuesday, November 11, 2025

Trump Strikes Deal With German Merck on Tariffs and IVF Costs

Date:

President Donald Trump announced a deal with Germany’s Merck KGaA to cut the price of some of its fertility medicines in exchange for relief from threatened tariffs, a step toward fulfilling his campaign promise of making IVF less expensive and more widely available in the US.

The administration will be issuing guidance to allow employers to offer fertility perks as excepted benefits, a category that includes supplemental health coverage like dental and vision. The guidance will allow employers to offer add-on coverage at a fixed cost for patients and employers.

The White House previously issued an executive order directing the administration to produce by May policy recommendations aimed at lowering the cost of expensive fertility treatments. The report never came. Now, five months later, it’s addressing the technology that can cost upwards of $15,000 per procedure.

The “result will be healthier pregnancies, healthier babies and many more beautiful American children,” Trump said at a press conference from the Oval Office on Thursday.

Fertility was a frequent theme on the campaign trail for Trump, who once called himself the “father of IVF” at a town hall. But it’s a sticking point for some of his conservative base, particularly after the Alabama Supreme Court ruled in 2023 that frozen embryos could be considered children. Some fertility clinics suspended treatment until the Republican governor signed legislation protecting providers from liability.

“Endorsing IVF from the White House podium should have some positive impact on awareness and adoption for IVF, even if there are no actual financial benefits being provided to employers to adopt those benefits,” wrote Michael Cherny, an analyst at Leerink Partners, in a note to investors.

Trump has been taking steps to lower health care prices. He struck deals with Pfizer Inc. and AstraZeneca Plc to delay threatened tariffs on their medicines in exchange for charging the same in the US as they do abroad. The pharmaceutical companies also agreed to cut the prices they offer to the Medicaid health insurance program for low-income and disabled Americans.

This article was generated from an automated news agency feed without modifications to text.

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

UPL Q2 Results: FY26 EBITDA guidance raised, revenue projection unchanged; Stock recovers

Shares of UPL Ltd. recovered from the lows of...

When and how to dispute your credit information report to safeguard your credit score

आपकी क्रेडिट रिपोर्ट में त्रुटियां और ग़लतियां आपके क्रेडिट...

Kashmiri Doctor arrested in Faridabad with Kalashnikov rifle, 2,900 Kg explosives; Police uncover ‘white-collar’ terror module

In a major counterterrorism breakthrough, police have arrested a...

SBI Funds Management IPO: Listing likely in 2026; Parent to divest 6.3% stake

India's largest lender, State Bank of India (SBI), has...